The upgrade is based on several factors, including Agnesian’s track record of strong operating cash flow margins, steadily improved liquidity ratios and distinctly leading market share.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Agnesian will continue to generate solid operating margins and sustain liquidity ratios.
More articles on healthcare finance:
How Christians are helping one another with medical bills: 5 things to know
These 2 states are targeting healthcare price transparency
Prism announces leadership changes, Zotec inks contract with Ohio radiology group & more — 7 RCM company key notes
